Literature DB >> 20442492

Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value.

Cathy B Moelans, Roel A de Weger, P J van Diest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20442492      PMCID： PMC4619176          DOI： 10.3233/CLO-2009-0502

Source DB:  PubMed          Journal:  Cell Oncol        ISSN： 1570-5870            Impact factor:   6.730


× No keyword cloud information.
  9 in total

1.  Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.

Authors:  Akishi Ooi; Takeru Oyama; Ritsuko Nakamura; Ryosuke Tajiri; Hiroko Ikeda; Sachio Fushida; Hiroyuki Nakamura; Yoh Dobashi
Journal:  Mod Pathol       Date:  2015-03-06       Impact factor: 7.842

2.  Active Stat3 and Her-2 as combined survival predictors show superiority to TNM staging system for postoperative patients with gastric cancer.

Authors:  Ke Sun; Meng Qing Xu; Hai Jun Zhang; Dan Dan Zhang; Wen Yue; Miao Miao Ma; Lin Tao; Wen Jie Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

3.  Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.

Authors:  Anoek H J Verschuur-Maes; Cathy B Moelans; Peter C de Bruin; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2014-04-02       Impact factor: 6.730

4.  Her-2/neu testing and therapy in gastroesophageal adenocarcinoma.

Authors:  Cathy B Moelans; Paul J van Diest; Anya N A Milne; G Johan A Offerhaus
Journal:  Patholog Res Int       Date:  2010-12-06

5.  Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients.

Authors:  Ahmed Abdel Hadi; Ali El Hindawi; Amal Hareedy; Heba Khalil; Ranya Al Ashiry; Shady Elia; Ahmed Sadek; Mona Magdy; Rafatt Atta; Amgad Anas; Hisham Bakr; Olfat Hammam
Journal:  Open Access Maced J Med Sci       Date:  2016-09-11

6.  Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.

Authors:  B B M Suelmann; A Rademaker; C van Dooijeweert; E van der Wall; P J van Diest; C B Moelans
Journal:  Cell Oncol (Dordr)       Date:  2022-07-06       Impact factor: 7.051

7.  Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.

Authors:  Chantal C H J Kuijpers; Cathy B Moelans; Henk-Jan van Slooten; Anja Horstman; John W J Hinrichs; Shaimaa Al-Janabi; Paul J van Diest; Mehdi Jiwa
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

8.  ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.

Authors:  Cathy B Moelans; Frederik Holst; Olaf Hellwinkel; Ronald Simon; Paul J van Diest
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

9.  Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study.

Authors:  Zhijian Wei; Lei Huang; Xinyue Zhang; Aman Xu
Journal:  BMC Gastroenterol       Date:  2020-10-15       Impact factor: 3.067
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.